EPL
RPID icon

EDBI Pte Ltd’s Rapid Micro Biosystems RPID Stock Holding History

EDBI Pte Ltd’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-24,515
Closed -$261K – 23
2021
Q4 		$261K Buy
+24,515
New +$383K 0.14% 15

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DCP
D1 Capital Partners New York $34.8B AUM 11.34% 1-Year Est. Return
KLM
Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $8.55M AUM 12.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return

EDBI Pte Ltd's RPID Position: Q1 2022 in Review

EDBI Pte Ltd sold out of Rapid Micro Biosystems (RPID) in Q1 2022, closing a stake of 24,515 shares — an estimated $261K sold.

EDBI Pte Ltd first reported a position in RPID in Q4 2021 and held it in 1 quarter. The position peaked at $261K in Q4 2021. 59 funds tracked by Wall St. Rank hold RPID as of Q1 2022.

  • EDBI Pte Ltd reported no remaining Rapid Micro Biosystems position as of Q1 2022 after selling out during the quarter.
  • EDBI Pte Ltd sold 24,515 Rapid Micro Biosystems shares in Q1 2022, an estimated $261K.
  • EDBI Pte Ltd first reported a position in Rapid Micro Biosystems in Q4 2021 and held it in 1 quarter.
  • EDBI Pte Ltd's Rapid Micro Biosystems position peaked at $261K in Q4 2021.
  • 59 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q1 2022.

Based on EDBI Pte Ltd's 13F filing for Q1 2022, filed 5 May 2022.